Search by keywords: and/or Explore by tags: Cancer CareCancer Care › Clinical TrialsCancer Care › DiagnosisCancer Care › Diagnosis › PathologyCancer Care › Genetic TestingCancer Care › Integrative MedicineCancer Care › Integrative Medicine › AcupunctureCancer Care › Medical TechnologyCancer Care › Medical Technology › Bone ScanCancer Care › Medical Technology › CTCancer Care › Medical Technology › MRICancer Care › NursingCancer Care › Pain ManagementCancer Care › Palliative CareCancer Care › Patient Care FacilitiesCancer Care › Prediction ToolsCancer Care › PreventionCancer Care › ScreeningCancer Care › Screening › ColonoscopyCancer Care › Screening › MammographyCancer Care › Screening › PSA TestingCancer Care › TreatmentCancer Care › Treatment › Blood & Marrow Stem Cell TransplantationCancer Care › Treatment › Plastic & Reconstructive SurgeryCancer Care › Treatment › Interventional Radiology Cancer Care › Treatment › Robotic SurgeryCancer Care › Treatment › ChemotherapyCancer Care › Treatment › Gene TherapyCancer Care › Treatment › Hormone TherapyCancer Care › Treatment › ImmunotherapyCancer Care › Treatment › Personalized MedicineCancer Care › Treatment › Radiation TherapyCancer Care › Treatment › SurgeryCancer Care › Treatment › Targeted TherapyCounseling & SupportCounseling & Support › CancerSmartCounseling & Support › Cognitive TestingCounseling & Support › PsychiatryCounseling & Support › Sexual HealthCounseling & Support › Social WorkCounseling & Support › Virtual ProgramsEducation & TrainingMiscellaneousMiscellaneous › FacebookMiscellaneous › WebsiteSurvivorshipSurvivorship › BridgesResearchResearch › Cancer Genetics & GenomicsResearch › Sloan Kettering InstituteResearch › Cancer Immunotherapy & VaccinesResearch › Cancer MetabolismResearch › CellBased TherapyResearch › Cell Signaling & RegulationResearch › Chemical BiologyResearch › Computational OncologyResearch › Developmental BiologyResearch › Discoveries & AdvancesResearch › Discoveries & Advances › Lab ResearchResearch › Discoveries & Advances › Clinical ResearchResearch › Discoveries & Advances › Health Outcomes, Epidemiology & StatisticsResearch › EpigeneticsResearch › Genome IntegrityResearch › Hematologic MalignanciesResearch › ImagingResearch › ImmunologyResearch › Metastasis & Drug ResistanceResearch › Microbiome & InflammationResearch › Molecular Pathology & DiagnosticsResearch › NanotechnologyResearch › Neuroscience & NeuroOncologyResearch › Solid Tumor OncogenesisResearch › Stem Cell BiologyResearch › Structural BiologyResearch › Systems BiologyResearch › Targeted TherapyResearch › Tumor MicroenvironmentGivingGiving › Donating BloodGiving › FundraisingGiving › The Society of MSKCCGiving › Volunteering 400 News Releases found ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal ‘Immunoablative’ Neoadjuvant Immunotherapy Clinical Trial Sunday, June 5, 2022 Breakthrough findings were presented at the 2022 ASCO Annual Meeting and published in The New England Journal of Medicine today by researchers at Memorial Sloan Kettering Cancer Center (MSK) confirming a clinical complete response in all 14 patients who received the immunotherapy treatment dostarlimab as a first-line treatment for mismatch repair-deficient (MMRd) locally advanced rectal cancer. This new approach of “immunoablative” therapy uses immunotherapy to replace surgery, chemotherapy and radiation to remove cancer. ASCO 2022: Practice-Changing Findings Identify HER2-Low as a Targetable Subset of Breast Cancer, Redefining Treatment for More Than 60 Percent of HER2-Negative Metastatic Breast Cancer Patients Sunday, June 5, 2022 New data from researchers at MSK featured in the 2022 ASCO Annual Meeting press program and simultaneously published in The New England Journal of Medicine highlights a novel antibody-drug conjugate that doubled progression-free survival in HER2-low metastatic breast cancer. Cancer Care Closer to Home: Physicians of Memorial Sloan Kettering Cancer Center and New York Cancer & Blood Specialists to Open New Cancer Care Facility in Brooklyn Thursday, June 2, 2022 Memorial Sloan Kettering Cancer Center (MSK) and New York Cancer & Blood Specialists (NYCBS), one of the fastest-growing community oncology practices in the nation, today announced plans to open a 39,000 sq ft facility in Brooklyn, New York, in early 2023. ASCO 2022: Memorial Sloan Kettering Cancer Center Experts To Present Significant Research at the American Society of Clinical Oncology Annual Meeting Tuesday, May 31, 2022 Physicians and scientists from MSK will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2022 ASCO Annual Meeting, June 3–7 in Chicago. MSK Awards & Appointments May 2022 Thursday, May 26, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Memorial Sloan Kettering Cancer Center Study Points to Expanded Genomic Testing that Aims To Benefit Children and Young Adults With Cancer Wednesday, May 18, 2022 By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults. Celebrating Exceptional Service in Nursing at Memorial Sloan Kettering Cancer Center: Third Annual Robbins Family Awards Wednesday, May 11, 2022 Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation are proud to announce today that 13 distinguished MSK nurses and one nursing team were recognized with the 2022 Robbins Family Award for Nursing Excellence. During National Nurses Week (May 6 – 12), MSK recognizes outstanding nurses for exemplary service. Ralph Lauren Corporate Foundation Announces $25 Million Commitment to Five Cancer Centers Across America With Goal of Reducing Disparities in Cancer Care in Underserved Communities Wednesday, May 11, 2022 The Ralph Lauren Corporate Foundation announced today that it's providing $25 million in new grant funding to expand or establish five Ralph Lauren cancer centers, aimed at reducing disparities in cancer care and access across underserved communities. The funding will benefit institutions including the Memorial Sloan Kettering (MSK) Ralph Lauren Center in Harlem. Cycle for Survival Makes History by Surpassing $300 Million for Rare Cancer Research Thursday, April 28, 2022 The Cycle for Survival community, along with founding partner, Equinox, achieves a historic fundraising milestone, fueling rare cancer research at Memorial Sloan Kettering. MSK Awards & Appointments April 2022 Wednesday, April 27, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Pagination Load More Book traversal links for News & Information Previous In the News Next MSK Awards & Appointments April 2022